{"id":"NCT00424047","sponsor":"Celgene","briefTitle":"A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma","officialTitle":"The Official Title is A Multi-center, Randomized, Parallel-group, Double-blind, Placebo Controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-01-01","primaryCompletion":"2005-11-01","completion":"2013-11-12","firstPosted":"2007-01-18","resultsPosted":"2015-03-04","lastUpdate":"2017-10-19"},"enrollment":351,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"CC-5013 plus dexamethasone","otherNames":["Revlimid","lenalidomide"]},{"type":"DRUG","name":"Dexamethasone plus Placebo","otherNames":["Dexamethasone","Placebo"]}],"arms":[{"label":"CC-5013 plus dexamethasone","type":"EXPERIMENTAL"},{"label":"Dexamethasone plus placebo","type":"EXPERIMENTAL"}],"summary":"To compare the efficacy of oral CC-5013 in combination with oral pulse high-dose dexamethasone to that of placebo and oral high-dose pulse dexamethasone as treatment for subjects with relapsed or refractory multiple myeloma.\"","primaryOutcome":{"measure":"Kaplan-Meier Estimate of Time to Tumor Progression (TTP)","timeFrame":"From randomization up to cut-off date of 03 August 2005; up to 24 months","effectByArm":[{"arm":"Lenalidomide Plus Dexamethasone","deltaMin":52.1,"sd":null},{"arm":"Placebo Plus Dexamethasone","deltaMin":20.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":69,"countries":["Australia","Austria","Belgium","France","Germany","Greece","Ireland","Israel","Italy","Poland","Spain","Sweden","Switzerland","Ukraine","United Kingdom"]},"refs":{"pmids":["18032762","21273172","19901114","18799726"],"seeAlso":["http://www.celgene.com/research-development/clinical-trials/clinical-trials-data-sharing/clinical-study-report-csr-synopses/purposes-of-posting-clinical-study-report-csr-synopses"]},"adverseEventsSummary":{"seriousAny":{"events":105,"n":176},"commonTop":["INSOMNIA","CONSTIPATION","DIARRHOEA NOS","ASTHENIA","ANAEMIA"]}}